局部前列腺癌的传统治疗方案包括前列腺切除术、放射治疗和主动监测。然而，前列腺切除术和放射治疗具有一定程度的发病率，包括尿失禁、勃起功能障碍和附近结构受伤的风险。主动监测会对患者带来疾病进展和心理困扰的风险。
适应症：Prostate Cancer
入组条件
纳入标准
- Men aged between 40 - 85 years
- Visible index lesion(s) on MRI
- Found to have localized prostate cancer after MRI-USG fusion targeted biopsy or USG-guided template biopsy: Clinical tumour stage \<=T2, or Gleason score \<=7, or PSA \<= 20 ng/ml
排除标准
- Patients unfit for contrast MRI exam
- Patients with active urinary tract infection
- Patients with bladder pathology including bladder stone and bladder cancer
- Patients with urethral stricture
- Patients with neurogenic bladder and/or sphincter abnormalities
- Patients who fail to give informed consent
入组条件维持 ClinicalTrials.gov 原始英文登记资料，实际入组资格以研究团队的正式评估与受试者知情同意书为准。资料来源：ClinicalTrials.gov，每两周自动更新，最后同步：2026年10月8日。